Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide Dose Finding in Non-Dialysis CKD
NCT00228436Phase 2Completed
- Sponsor
- Affymax, Inc.
- Start
- Sep 2005
- Primary completion
- Nov 2007
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 2
01
Overview
A Phase 2 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Affymax, Inc.. Started Sep 2005; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00228436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228436.